Denervation for hypertension

Most patients have blood pressure – about 50% have high BP. 100M people have it.

Secondary hypertension ( causes which are not primary genetic etc)

sleep apnea

hyperthyroidism

hyperaldosteronism

Coartation of arota (pinching of artery)

Renal artery stenosis (plaque in kidney artery).

Kidney wants blood pressure and hence they sometimes can cause high blood pressure)

Cushings syndrome

Medications – immunotherapeutics can raise bp in chemotherapy)

Medicated – even 80% are not at goal.

More treatment helps

Lifestyle changes – reduce salt intake, exercise and dietary changes, decrease alcohol

Therapy: Calcium channel blockers, ACE inhibitor, angiotension receptor blockers, diuretics, spironolactone.

There has not been too much innovation and liability for side – effects. This leads to nonadherence.

Renal artery denervation – Was done in 2007 through catheter. And did lower blood pressure. Kidney’s are greedy – they are very well innervated. Feedback loop to brain – they keep blood flow up. It becmoes overactive smpathetic system.

Nerves near the kidney are more important to ablate.

Radiofrequency mediated renal artery denervation – casuse a 10mm Hg drop in 24 hr ambulatory blood pressure primary endpoint.

Also ultrasound mediated rentar artery denervation.

Very rigorous study (Medtronic).

Contraindications – increased bleeding risk or CKD or eGFR <45 ml/min/1.73m2

, previous renal artery innervation.

All the equipment are put through a catheter.

Treatment algorithm – first treatment and as last resort use kidney denervation.

Usually bilateral – specific energy to burn only the specific neurons.

Magnesium is a smooth muscle relaxant and so magnesium can cause it to relax. And sometimes they give to pregnant women. Mg supplement may not have an effect.

Measure blood pressure technique. –Usually do it just once after stting down and relaxing for 5 minutes.

Denervation does not change the blood flow to the kidney but it does lower BP.

Global changes – you see a change in the RAS system. But they have not looked – it is more about clinical outcomes.

Sometimes carotid artery can also be explored in other vascular beds.

Similar Posts

  • |

    ALS and TDP43

    Almost 90% of ALS is thought to be sporadic. The reasons are not well understood and thought to be oxidative stress, damaged endoplasmic reticulum, mitochondria, cytoskeleton or misregulation of RNA pathways. One protein implicated is TDP43 which sits as a junction of ALS pathogenic path by binding to RNA modulation synthesis, splicing, stability and transport….

  • | |

    TDP43

    TDP43 (a nuclear DNA-RNA binding protein) is involved in splicing, RNA transport and stability in neurons. It was first identified as a pyrimidine rich TAR DNA sequence in HIV type 1 gene to modulate HIV gene expression. In 95% of the ALS patients, TDP43 is abnormal located within the cell and may also be aggregated,…

  • |

    Open source protein models

    A company called Profluent (profluent.bio) has been developing protein models that can be used for designing new proteins (https://www.nature.com/articles/s41587-022-01618-2), modeling of new CRISPR-Cas sequences (https://www.nature.com/articles/s41586-025-09298-z) and developing LLM for protein generation (https://www.biorxiv.org/content/10.1101/2025.11.12.688125v1.article-info). What is amazing is that they have open sourced all their models and Profluent-E1 is available in GitHub to download and use. (https://github.com/Profluent-AI/E1)…

  • |

    Sequencing

    It is amazing how good genetic sequencing is getting these days and reasonable enough to get 30x whole genome sequence that enables detailed analysis for a variety of conditions. The costs are so low that it is now possible for almost everyone to do it and also analyze the data. One provider with a catchy…

  • |

    Muscarinic drugs and receptors

    There are many G-protein coupled receptors and one of the major categories for neurological drug development are called muscarinic receptors because they were first known to be activated by a mushroom alkaloid called muscarine. The isolation and characterization of muscarine was first reported by chemists in 1869! Muscarine works by mimicking the neurotransmitter acteylcholine on…